Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Midgut malrotation complicated by small bowel obstruction in an 80-year-old woman: A case report.

Haqqani M, Seetharaman M, Teo R, Adkisson C, Nessen M, Dauer M, Kim PK.

Int J Surg Case Rep. 2019;63:89-93. doi: 10.1016/j.ijscr.2019.09.008. Epub 2019 Sep 18.

2.
3.

Skeletal malformations of Meox1-deficient zebrafish resemble human Klippel-Feil syndrome.

Dauer MVP, Currie PD, Berger J.

J Anat. 2018 Dec;233(6):687-695. doi: 10.1111/joa.12890. Epub 2018 Oct 2.

PMID:
30277257
4.

Selective association of nonaspirin NSAIDs with risk of diverticulitis.

Reichert MC, Krawczyk M, Appenrodt B, Casper M, Friesenhahn-Ochs B, Grünhage F, Jüngst C, Zimmer V, Lammert F, Dauer M.

Int J Colorectal Dis. 2018 Apr;33(4):423-430. doi: 10.1007/s00384-018-2968-z. Epub 2018 Feb 6.

PMID:
29411119
5.

Correction: Panel of three novel serum markers predicts liver stiffness and fibrosis stages in patients with chronic liver disease.

Krawczyk M, Zimmermann S, Hess G, Holz R, Dauer M, Raedle J, Lammert F, Grünhage F.

PLoS One. 2017 Jun 2;12(6):e0179205. doi: 10.1371/journal.pone.0179205. eCollection 2017.

6.

Panel of three novel serum markers predicts liver stiffness and fibrosis stages in patients with chronic liver disease.

Krawczyk M, Zimmermann S, Hess G, Holz R, Dauer M, Raedle J, Lammert F, Grünhage F.

PLoS One. 2017 Mar 16;12(3):e0173506. doi: 10.1371/journal.pone.0173506. eCollection 2017. Erratum in: PLoS One. 2017 Jun 2;12 (6):e0179205.

7.

Proapoptotic and antiapoptotic proteins of the Bcl-2 family regulate sensitivity of pancreatic cancer cells toward gemcitabine and T-cell-mediated cytotoxicity.

Bauer C, Hees C, Sterzik A, Bauernfeind F, Mak'Anyengo R, Duewell P, Lehr HA, Noessner E, Wank R, Trauzold A, Endres S, Dauer M, Schnurr M.

J Immunother. 2015 Apr;38(3):116-26. doi: 10.1097/CJI.0000000000000073.

PMID:
25751501
8.

Mycobacterium abscessus infection in a burn intensive care unit patient.

Vaghaiwalla T, Satahoo SS, Zarifa R, Dauer M, Davis JS, Dearmas D, Namias N, Pizano LR, Schulman CI.

Surg Infect (Larchmt). 2014 Dec;15(6):847-9. doi: 10.1089/sur.2014.052.

PMID:
25493353
9.

Proinflammatory progranulin antibodies in inflammatory bowel diseases.

Thurner L, Stöger E, Fadle N, Klemm P, Regitz E, Kemele M, Bette B, Held G, Dauer M, Lammert F, Preuss KD, Zimmer V, Pfreundschuh M.

Dig Dis Sci. 2014 Aug;59(8):1733-42. doi: 10.1007/s10620-014-3089-3. Epub 2014 Mar 4.

PMID:
24591016
10.

Concomitant gemcitabine therapy negatively affects DC vaccine-induced CD8(+) T-cell and B-cell responses but improves clinical efficacy in a murine pancreatic carcinoma model.

Bauer C, Sterzik A, Bauernfeind F, Duewell P, Conrad C, Kiefl R, Endres S, Eigler A, Schnurr M, Dauer M.

Cancer Immunol Immunother. 2014 Apr;63(4):321-33. doi: 10.1007/s00262-013-1510-y. Epub 2014 Jan 3.

PMID:
24384835
11.

Relationship between effective population size, inbreeding and adult fitness-related traits in a steelhead (Oncorhynchus mykiss) population released in the wild.

Naish KA, Seamons TR, Dauer MB, Hauser L, Quinn TP.

Mol Ecol. 2013 Mar;22(5):1295-309. doi: 10.1111/mec.12185. Epub 2013 Feb 4.

PMID:
23379933
12.

Increased potency of cardiac stem cells compared with bone marrow mesenchymal stem cells in cardiac repair.

Oskouei BN, Lamirault G, Joseph C, Treuer AV, Landa S, Da Silva J, Hatzistergos K, Dauer M, Balkan W, McNiece I, Hare JM.

Stem Cells Transl Med. 2012 Feb;1(2):116-24. doi: 10.5966/sctm.2011-0015. Epub 2012 Feb 7.

13.

Recurrent pancreatitis caused by a huge intraluminal duodenal diverticulum.

Reichert MC, Bittenbring JT, Fries P, Zimmer V, Lammert F, Dauer M.

J Gastrointestin Liver Dis. 2012 Jun;21(2):126. No abstract available.

14.

ISCOMATRIX adjuvant combines immune activation with antigen delivery to dendritic cells in vivo leading to effective cross-priming of CD8+ T cells.

Duewell P, Kisser U, Heckelsmiller K, Hoves S, Stoitzner P, Koernig S, Morelli AB, Clausen BE, Dauer M, Eigler A, Anz D, Bourquin C, Maraskovsky E, Endres S, Schnurr M.

J Immunol. 2011 Jul 1;187(1):55-63. doi: 10.4049/jimmunol.1004114. Epub 2011 May 25.

15.

Dendritic cell-based vaccination of patients with advanced pancreatic carcinoma: results of a pilot study.

Bauer C, Dauer M, Saraj S, Schnurr M, Bauernfeind F, Sterzik A, Junkmann J, Jakl V, Kiefl R, Oduncu F, Emmerich B, Mayr D, Mussack T, Bruns C, Rüttinger D, Conrad C, Jauch KW, Endres S, Eigler A.

Cancer Immunol Immunother. 2011 Aug;60(8):1097-107. doi: 10.1007/s00262-011-1023-5. Epub 2011 May 6.

PMID:
21547597
16.

One less ulcer, one extra pylorus.

Zimmer V, Dauer M, Lammert F.

Dig Liver Dis. 2011 Jul;43(7):e13. doi: 10.1016/j.dld.2010.11.018. Epub 2011 Jan 19. No abstract available.

PMID:
21251890
17.

An ISCOM vaccine combined with a TLR9 agonist breaks immune evasion mediated by regulatory T cells in an orthotopic model of pancreatic carcinoma.

Jacobs C, Duewell P, Heckelsmiller K, Wei J, Bauernfeind F, Ellermeier J, Kisser U, Bauer CA, Dauer M, Eigler A, Maraskovsky E, Endres S, Schnurr M.

Int J Cancer. 2011 Feb 15;128(4):897-907. doi: 10.1002/ijc.25399.

18.

Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome.

Bauer C, Duewell P, Mayer C, Lehr HA, Fitzgerald KA, Dauer M, Tschopp J, Endres S, Latz E, Schnurr M.

Gut. 2010 Sep;59(9):1192-9. doi: 10.1136/gut.2009.197822. Epub 2010 May 4.

PMID:
20442201
19.

Mandatory and optional function tests for biliary disorders.

Dauer M, Lammert F.

Best Pract Res Clin Gastroenterol. 2009;23(3):441-51. doi: 10.1016/j.bpg.2009.04.001. Review.

PMID:
19505670
20.

Dendritic cell-based cancer vaccination: quo vadis?

Dauer M, Schnurr M, Eigler A.

Expert Rev Vaccines. 2008 Sep;7(7):1041-53. doi: 10.1586/14760584.7.7.1041. Review.

PMID:
18767953
21.

Combined use of toll-like receptor agonists and prostaglandin E(2) in the FastDC model: rapid generation of human monocyte-derived dendritic cells capable of migration and IL-12p70 production.

Dauer M, Lam V, Arnold H, Junkmann J, Kiefl R, Bauer C, Schnurr M, Endres S, Eigler A.

J Immunol Methods. 2008 Sep 15;337(2):97-105. doi: 10.1016/j.jim.2008.07.003. Epub 2008 Jul 25.

PMID:
18657542
22.

Do we need gastric acid?

Pohl D, Fox M, Fried M, Göke B, Prinz C, Mönnikes H, Rogler G, Dauer M, Keller J, Lippl F, Schiefke I, Seidler U, Allescher HD; Kandahar Study Group.

Digestion. 2008;77(3-4):184-97. doi: 10.1159/000142726. Epub 2008 Jul 2. Review.

23.

P2Y receptor signaling regulates phenotype and IFN-alpha secretion of human plasmacytoid dendritic cells.

Shin A, Toy T, Rothenfusser S, Robson N, Vorac J, Dauer M, Stuplich M, Endres S, Cebon J, Maraskovsky E, Schnurr M.

Blood. 2008 Mar 15;111(6):3062-9. Epub 2007 Nov 9.

PMID:
17993619
24.

Dendritic cell-based vaccination combined with gemcitabine increases survival in a murine pancreatic carcinoma model.

Bauer C, Bauernfeind F, Sterzik A, Orban M, Schnurr M, Lehr HA, Endres S, Eigler A, Dauer M.

Gut. 2007 Sep;56(9):1275-82. Epub 2007 Mar 29.

25.

The ICE inhibitor pralnacasan prevents DSS-induced colitis in C57BL/6 mice and suppresses IP-10 mRNA but not TNF-alpha mRNA expression.

Bauer C, Loher F, Dauer M, Mayer C, Lehr HA, Schönharting M, Hallwachs R, Endres S, Eigler A.

Dig Dis Sci. 2007 Jul;52(7):1642-52. Epub 2007 Mar 28.

PMID:
17393315
27.

IFN-alpha promotes definitive maturation of dendritic cells generated by short-term culture of monocytes with GM-CSF and IL-4.

Dauer M, Schad K, Junkmann J, Bauer C, Herten J, Kiefl R, Schnurr M, Endres S, Eigler A.

J Leukoc Biol. 2006 Aug;80(2):278-86. Epub 2006 Jun 12.

PMID:
16769767
28.

Chemosensitization of pancreatic carcinoma cells to enhance T cell-mediated cytotoxicity induced by tumor lysate-pulsed dendritic cells.

Dauer M, Herten J, Bauer C, Renner F, Schad K, Schnurr M, Endres S, Eigler A.

J Immunother. 2005 Jul-Aug;28(4):332-42.

PMID:
16000951
29.

FastDC derived from human monocytes within 48 h effectively prime tumor antigen-specific cytotoxic T cells.

Dauer M, Schad K, Herten J, Junkmann J, Bauer C, Kiefl R, Endres S, Eigler A.

J Immunol Methods. 2005 Jul;302(1-2):145-55.

PMID:
15992809
30.

A rare cause of gastrointestinal bleeding in a patient with hyper-IgE syndrome.

Götzberger M, Schlesinger A, Dauer M, Heldwein W, Jansson A, Renner E, Belohradsky BH.

Gut. 2004 Oct;53(10):1430, 1436. No abstract available.

31.

Development of a new protocol for 2-day generation of mature dendritic cells from human monocytes.

Obermaier B, Dauer M, Herten J, Schad K, Endres S, Eigler A.

Biol Proced Online. 2003;5:197-203. Epub 2003 Oct 24.

32.

The interleukin-1 beta-converting enzyme inhibitor pralnacasan reduces dextran sulfate sodium-induced murine colitis and T helper 1 T-cell activation.

Loher F, Bauer C, Landauer N, Schmall K, Siegmund B, Lehr HA, Dauer M, Schoenharting M, Endres S, Eigler A.

J Pharmacol Exp Ther. 2004 Feb;308(2):583-90. Epub 2003 Nov 10.

PMID:
14610233
33.
34.

Mature dendritic cells derived from human monocytes within 48 hours: a novel strategy for dendritic cell differentiation from blood precursors.

Dauer M, Obermaier B, Herten J, Haerle C, Pohl K, Rothenfusser S, Schnurr M, Endres S, Eigler A.

J Immunol. 2003 Apr 15;170(8):4069-76.

35.

The specific type-4 phosphodiesterase inhibitor mesopram alleviates experimental colitis in mice.

Loher F, Schmall K, Freytag P, Landauer N, Hallwachs R, Bauer C, Siegmund B, Rieder F, Lehr HA, Dauer M, Kapp JF, Endres S, Eigler A.

J Pharmacol Exp Ther. 2003 May;305(2):549-56. Epub 2003 Feb 11.

PMID:
12606674
36.

Determination of thiopurine S-methyltransferase phenotype using thin-layer chromatography and quantitative scanning.

Dauer M, Schulze J, Loher F, Endres S, Eigler A.

Eur J Clin Pharmacol. 2002 Apr;58(1):41-4. Epub 2002 Mar 12.

PMID:
11956672
37.

Apoptotic pancreatic tumor cells are superior to cell lysates in promoting cross-priming of cytotoxic T cells and activate NK and gammadelta T cells.

Schnurr M, Scholz C, Rothenfusser S, Galambos P, Dauer M, Röbe J, Endres S, Eigler A.

Cancer Res. 2002 Apr 15;62(8):2347-52.

38.
39.

Comparison of voice analysis systems for perturbation measurement.

Bielamowicz S, Kreiman J, Gerratt BR, Dauer MS, Berke GS.

J Speech Hear Res. 1996 Feb;39(1):126-34.

PMID:
8820704
40.

Noncutaneous benign fibrous histiocytoma of the head and neck.

Bielamowicz S, Dauer MS, Chang B, Zimmerman MC.

Otolaryngol Head Neck Surg. 1995 Jul;113(1):140-6. Review. No abstract available.

PMID:
7603710
41.

Natural environmental radioactivity in south Florida sands and soils, February-June 1968.

Keefer DH, Dauer M.

Radiol Health Data Rep. 1970 Sep;11(9):441-8. No abstract available.

PMID:
5477853
42.

Evaluation of the Fricke dosimeter with other dosimetry systems.

Oller WL, Menker DF, Dauer M.

Health Phys. 1969 Nov;17(5):653-9. No abstract available.

PMID:
5359568
43.

Behavior of marrow stem cells in irradiated and non-irradiated mice after treatment with cytotoxic agents.

Berman I, McCabe B, Dauer MM.

Radiat Res. 1969 May;38(2):296-306. No abstract available.

PMID:
4977149
44.

Some examples and limitations of the RADS and ARADS computer programs.

Plato PA, Menker DF, Dauer M.

Health Phys. 1969 Mar;16(3):383-91. No abstract available.

PMID:
5787755
45.

Melittin used as a protective agent against x-irradiation.

Ginsberg NJ, Dauer M, Slotta KH.

Nature. 1968 Dec 28;220(5174):1334. No abstract available.

PMID:
5701352
46.

A comparison of leak test procedures for sealed radium sources.

Morris JO, Menker DF, Dauer M.

Am Ind Hyg Assoc J. 1968 May-Jun;29(3):279-84. No abstract available.

PMID:
5658093
47.

Effects of gamma irradiation with Co60 on erythrocytes of female Fischer rats.

Ring GC, Dauer M, Johnson B, James G.

J Gerontol. 1967 Oct;22(4):456-8. No abstract available.

PMID:
6070005
48.

Computer model for the prediction of the dispersion of airborne radioactive pollutants.

Plato PA, Menker DF, Dauer M.

Health Phys. 1967 Oct;13(10):1105-15. No abstract available.

PMID:
6048958
49.

Radiosensitivity of the tamarin to whole-body irradiation.

Porter RP, Vuksanovic M, Dauer M.

Radiology. 1966 Jul;87(1):74. No abstract available.

PMID:
4957354
50.

Evaluation of film badge dosimeters for occupational radiation exposure.

Menker DF, Dauer M.

Ind Med Surg. 1965 Sep;34(9):700-4. No abstract available.

PMID:
5213272

Supplemental Content

Support Center